B+
Bull case
25%
Probability
Target price
$1.10
Analysis reference price unavailable
Analysis 2026-10-22 · RankAlpha Sentiment Codex
CGC
Canopy GrowthBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Revenue growth across all reported businesses, higher adjusted gross margin, and a narrower adjusted EBITDA loss could support a turnaround if MTL integration also reduces cash burn. [#SEC-8K-2026-08-07]
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
MTL contributed to Canadian medical and adult-use growth, limiting evidence of organic acceleration; reduced Veterans Affairs Canada reimbursement also pressured medical cannabis results. [#SEC-8K-2026-08-07]
Momentum
92
Value
41
Sentiment
64
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $0.73 · Bull $1.10 · Bear $0.42Analysis 2026-10-22; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-11-02 • Vendor: Data Vendor v1
Scores
As of 2026-11-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-10-22 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-11-02
Investment thesis
As of 2026-11-02
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-11-02. Definitions
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $1.53
Why
Momentum92 · Δ7d -
Value41 · Δ7d +0.0
Sentiment64 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Sentiment remains the lead driver in the composite.
Contradictions & invalidation
- • MTL contributed to Canadian medical and adult-use growth, limiting evidence of organic acceleration; reduced Veterans Affairs Canada reimbursement also pressured medical cannabis results. [#SEC-8K-2026-08-07]
- • Nasdaq bid-price noncompliance could require a reverse split or lead to delisting proceedings if not cured; the current notice has no immediate listing effect. [#8-K-2026-10-16]
- • Q1 free cash outflow widened despite improved adjusted earnings, some Canadian growth benefited from MTL, and the sub-$1 share price created a Nasdaq compliance deadline.
Catalyst clock
2026-10-23
Share-consolidation vote
Lead driver: Sentiment · See AI snapshot
Momentum
92
18% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
41
43% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
-0.2
Sentiment
64
39% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade B. Momentum 92.2 / Value 40.6 / Sentiment 64.5
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-10-22. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$0.73
Analysis reference price unavailable
Analysis 2026-10-22 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$0.42
Analysis reference price unavailable
Analysis 2026-10-22 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-11-02
Fundamentals (TTM)
As of 2026-11-02
Market Cap
$309.6M
Beta
0.57
Shares Out
419.57M
P/E (TTM) · Derived
-1.2
P/S (TTM)
-
P/FCF (TTM) · Derived
-4.30
Rev YoY
+12.5%
EPS YoY
-85.5%
Gross Margin
+18.2%
Op Margin
-25.4%
Net Debt
-$65.22M
Current Ratio
3.04
As of 2026-11-02 • Updated nightlySource: Internal modelMethods & Data